Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Attitudinal scaling
A two-dimensional technique in which the respondent determines the two most important characteristics of a product. Attitudinal scaling is most commonly applied to characteristics such as price and quality. The purpose of Attitudinal scaling is to understand better the participant's attitude towards the product or service.
See also:
Product attributes
Market Research
Data Collection
Related terms
Data Protection Act, Marketing metrics, Oligopsony, Market segmentation, Sensitive data, Environmental scanning, Business plan, Comparative advertising, Grey market, Internal analysis, Field experiments, Corporate fact sheet, Procurement officer/manager, Guerrilla marketing, Strategic business unit (SBU),
COVID-19 Updates and Daily News
Featured jobs
- Senior Account Executive, Medical/ Brand Communications, London
-
Highly competitive salary
-
Consultant Dermatologist (Freelance)
-
£110-180ph
-
Senior Health Psychologist, London
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
-
Head of Health Psychology, London
-
Highly competitive salary
- Recognising HIV Vaccine Awareness Day
- Almirall and Evotec team up in multi-target dermatology alliance
- NICE recommends AstraZeneca’s Imfinzi for adults with non-small cell lung cancer
- Scientists discover new approach to treat brain tumours
- AstraZeneca’s COVID-19 vaccine receives EMA approval for use as third-dose booster
- EMA accepts Valneva’s marketing authorisation application for COVID-19 vaccine
- Part 1 of the Medscape video interview series
- NHS England appoints Chris Hopson as its new chief strategy officer
- Almirall launches Actinic Keratosis Global Day during Skin Cancer Awareness Month
- Pfizer/BioNTech COVID-19 vaccine produces strong immune response in children
- AbbVie submits Parkinson’s disease therapy to FDA
- When is an agency not an agency?
- Jardiance is first diabetes drug to improve CV outcomes
- Roche shares new positive Ocrevus data for MS patients
- EMA reviewing Biogen’s potential Alzheimer’s drug for use in the EU
- Almirall and Inserm Transfert to develop innovative vitiligo treatments
- How to plan, execute and refine an excellent congress experience
- GPs will play a pivotal role in integrated care
